Methods and implementation of a pediatric asthma pharmacogenomic study in the emergency department setting
- PMID: 33017130
- PMCID: PMC7536354
- DOI: 10.1097/FPC.0000000000000414
Methods and implementation of a pediatric asthma pharmacogenomic study in the emergency department setting
Abstract
Objectives: The emergency department (ED) is a challenging setting to conduct pharmacogenomic studies and integrate that data into fast-paced and potentially life-saving treatment decisions. Therefore, our objective is to present the methods and feasibility of a pilot pharmacogenomic study set in the ED that measured pediatric bronchodilator response (BDR) during acute asthma exacerbations.
Methods: This is an exploratory pilot study that collected buccal swabs for DNA and measured BDR during ED encounters for pediatric asthma exacerbations. We evaluated the study's feasibility with a qualitative analysis of ED provider surveys and quantitatively by the proportion of eligible patients enrolled.
Results: We enrolled 59 out of 90 patients (65%) that were identified and considered eligible during a 5-month period (target enrollment 60 patients over 12 months). The median patient age was 7 years (interquartile range 4-9 years), 61% (N = 36) were male, and 92% (N = 54) were African American. Quality DNA collection was successful for all 59 patients. The ED provider survey response rate was 100%. Most ED providers reported that the study did not impact their workflow (98% of physicians, 88% of nurses, and 90% of respiratory therapists). ED providers did report difficulties with spirometry in the younger age group.
Conclusions: Pharmacogenomic studies can be conducted in the ED setting, and enroll a younger patient population with a high proportion of minority participants. By disseminating this study's methods and feasibility analysis, we aim to increase interest in pharmacogenomic studies set in the ED and aimed toward future ED-based pharmacogenomic decision-making.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures


Similar articles
-
Single Nucleotide Polymorphisms (SNPs) in PRKG1 & SPATA13-AS1 are associated with bronchodilator response: a pilot study during acute asthma exacerbations in African American children.Pharmacogenet Genomics. 2021 Sep 1;31(7):146-154. doi: 10.1097/FPC.0000000000000434. Pharmacogenet Genomics. 2021. PMID: 33851947 Free PMC article. Review.
-
Development and Pilot Testing of a Computerized Asthma Kiosk to Initiate Chronic Asthma Care in a Pediatric Emergency Department.Pediatr Emerg Care. 2018 Oct;34(10):e190-e195. doi: 10.1097/PEC.0000000000001630. Pediatr Emerg Care. 2018. PMID: 30281581
-
Provider adherence to a clinical practice guideline for acute asthma in a pediatric emergency department.Acad Emerg Med. 2001 Dec;8(12):1147-52. doi: 10.1111/j.1553-2712.2001.tb01131.x. Acad Emerg Med. 2001. PMID: 11733292
-
Urban primary care physicians' perceptions about initiation of controller medications during a pediatric emergency department visit for asthma.Pediatr Emerg Care. 2012 Jan;28(1):8-11. doi: 10.1097/PEC.0b013e31823ed4c4. Pediatr Emerg Care. 2012. PMID: 22193691
-
Use of a National Database to Assess Pediatric Emergency Care Across United States Emergency Departments.Acad Emerg Med. 2018 Dec;25(12):1355-1364. doi: 10.1111/acem.13489. Epub 2018 Jul 4. Acad Emerg Med. 2018. PMID: 29858524
Cited by
-
Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma.Genes (Basel). 2022 Mar 28;13(4):599. doi: 10.3390/genes13040599. Genes (Basel). 2022. PMID: 35456405 Free PMC article. Review.
References
-
- Ashley EA. “Towards precision medicine.” Nat Rev Genet. 2016;17:507–22. - PubMed
-
- U.S. Food and Drug Administration, Table of Pharmacogenetic Associations. Available at: https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogen.... Accessed May 14, 2020.